First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.

First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer. 2005 Sep 15; 104(6):1138-48.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Brachytherapy
Breast Neoplasms
Esthetics
Female
Humans
Middle Aged
Registries
Reproducibility of Results

authors with profiles

HENRY MARK KUERER